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INTRODUCTION 
Cardiovascular disease is a conglomerate of diseases 
that affect the heart and the arterial system in the body. It 
remains the number one cause of death in developed 
countries. In Malaysia, between the years 2000 and 2004, 
20-25% of deaths in Government hospitals were due to 
cardiovascular disease [1].  
Coronary artery disease (CAD) is characterised by 
the presence of atherosclerotic plaques in the coronary 
arteries. Coronary artery calcification is part of the 
development of these atherosclerotic plaques. These 
plaques progressively narrow the arterial lumen and 
hence impair blood flow. The reduction in coronary 
artery flow may be asymptomatic or symptomatic, may 
occur with or without exertion, and may culminate in a 
myocardial infarction, depending on the severity of the 
obstruction and rapidity of development. 
Various investigational modalities are available for 
the detection of CAD. These include electrocardiography, 
echocardiography and radionuclide imaging. Lately, 
there has been increasing awareness in newer imaging 
techniques such as Computer Tomography (CT) and 
Magnetic Resonance Imaging (MRI) in diagnosing CAD. 
CT as an imaging modality has been around for 
more than three decades. However, only in the last few 
years with the introduction of the multislice computer 
tomography (MSCT), has it allowed adequate imaging 
and interpretation of the status of the coronary arteries 
and its related structures. It is a novel technique, in that it 
allows non-invasive visualisation of the coronary artery 
lumen. Although the gold standard for diagnosing 
obstructive coronary disease is still invasive coronary 
angiography, cardiac CT, in certain clinical situations, 
may be an acceptable alternative [2, 3, 4, 5]. Coronary 
calcium, a marker of plaque burden, can also be 
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quantified with this method, and to a certain extent, 
plaque composition can be characterised [6].  
The growth and availability of MSCT services in 
Malaysia have been immense. Therefore, it is important 
for the local medical profession to understand the 
requirements to obtain a minimum dataset for adequate 
interpretation of the cardiac study, and most importantly 
patient selection, preparation and safety. In order to 
make full use of this powerful imaging tool in daily 
clinical practice to increase the diagnostic yield, its 
potential and limitations have to be understood. This 
document aims to outline the requirements for cardiac 
CT, current indications, safety, reporting and training 
issues in Malaysia. The committee understands that CT 
technology and applications are evolving rapidly, and it 
is only pertinent that this document will be constantly 
revised to parallel the developments. 
RATIONALE OF CARDIAC CT  
Comprehensive cardiac assessment requires 
information on coronary vascular anatomy, cardiac 
morphology, function, perfusion, metabolism and tissue 
characterisation. At the moment, no single imaging 
modality is able to successfully achieve accurate global 
assessment of the heart, which is a difficult organ to 
image because of its rapid, complex, cyclical, variable 
rate-dependent motion and its small vessels. 
Cross-sectional CT imaging of the coronary arteries 
was first performed with the electron beam CT in 1984. 
However, low spatial resolution and high image noise 
limited the image quality. Since 1998, with the 
introduction of the 4-slice mechanical CT scanners and 
subsequently 16- and 64-slice CT scanners with higher 
spatial and temporal resolutions, accurate visualisation of 
the coronary arteries, cardiac anatomy as well as 
functional imaging are possible. At the time of writing, 
the evolving CT technology has presented us with 
various new developments, including dual source CT 
scanners as well as 320-slice CT scanners (which boast 
greater anatomical coverage and shorter scan time).  
Invasive imaging techniques, especially selective 
conventional
 coronary angiography, will remain vital in 
planning and guiding
  catheter-based and surgical 
treatment of significantly stenotic
  coronary lesions. 
However, because coronary angiography is associated 
with a small but not negligible risk of complications 
(inherent in invasive procedures), inconvenience to 
patients and significant costs, coronary CT angiography 
(CTA) is an attractive alternative to invasive selective 
coronary angiography, with the potential to reduce the 
number of purely diagnostic angiograms. In particular, 
patients with intermediate likelihood of CAD may 
benefit from coronary CTA [7].  
Cardiac CT is usually performed as a two-part 
examination – first, the coronary artery calcium score, 
and secondly, the coronary artery CT angiogram. 
The calcium score measures the amount of calcified 
plaques in the coronary arteries as a surrogate marker for 
atherosclerotic disease. The majority of published studies 
have reported that the total amount of coronary calcium 
(usually expressed as the Agatston score) predicts 
coronary disease events beyond standard risk factors. 
Calcium score is useful given a negative CT test as 
atherosclerotic disease is less likely (negative predictive 
value 96-100%). In addition, intermediate risk patients 
(10-20% 10-year Framingham Risk Score) may benefit 
from a calcium score by refining clinical risk prediction 
and selecting patients for more aggressive risk factor 
modification and pharmacological intervention [8, 9].  
Coronary CTA has been shown to be accurate in the 
detection and quantification of haemodynamically 
significant stenosis. Several studies have shown that the 
overall sensitivity is between 95% and 99%, and 
specificity 93-96% for detection of coronary artery 
stenosis [10-12]. Sensitivity, specificity, and the negative 
predictive
 value (NPV) of 64-slice MSCT per patient are 
approximately 97%, 79%, and 96%, respectively [13]. In 
addition, coronary CTA is able to display non-calcified 
plaque and vascular remodelling with good correlation 
with intravascular ultrasound [7].  
The dataset obtained during the contrast-enhanced 
coronary scans can also be processed to obtain functional 
information of the heart. 
This document represents a joint effort between the 
National Heart Association of Malaysia and the College 
of Radiology (Malaysia) to: 
1.  Present a summary of existing medical 
literature and data on cardiac CT. As this is an 
emerging technology, there are still areas of 
uncertain significance which are being explored 
in current studies. The appropriate and optimal 
application of this technology must be 
individually tailored to each patient taking into 
account risks, benefits, cost effectiveness and 
availability of alternative technology.  
2.  Make suggestions regarding the training of 
physicians wishing to participate in this field. 
The current criteria are formulated based on 
prevailing practices and conditions in Malaysia 
with reference to accepted standard clinical 
practices worldwide.  
REQUIREMENTS OF CARDIAC CT  
Imaging of the heart using CT demands exact 
performance requirements from the scanner. These 
requirements include:  
(a) Minimisation of cardiac motion artifacts 
This is the most critical aspect of cardiac imaging. 
The coronary arteries go through a series of complex 
movements during the cardiac cycle. Therefore, in order 
to image the coronary artery successfully, a scanner with 
a high temporal resolution is needed. One method of 
achieving this is by reducing the gantry rotation time 
[14]. The 4-slice CT scanners have rotation times of 
0.5  sec. Newer scanners have gantry rotation times of KH Sim et al. Biomed Imaging Interv J 2008; 4(4):e41   3 
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0.42 sec or less. Currently a 64-slice CT scanner has a 
temporal resolution of 165 msec. 
Furthermore, the artifacts from cardiac motion can 
be further suppressed by imaging during the quiescent 
phase of the cardiac cycle [14]. This can be achieved by 
synchronising the image acquisition and image 
reconstruction with the ECG signal of the patient. This is 
done by using cardiac gating mechanism during scanning. 
Two ECG gating techniques are employed namely 
prospective ECG triggering and retrospective ECG 
triggering. 
Another method that can be employed to improve 
the temporal resolution is to combine projection data 
from consecutive cardiac cycles [14]. This is called 
multi-segment reconstruction and provides a significant 
improvement in the temporal resolution by combining 
data from as many as four cardiac cycles. However, this 
technique relies heavily on the regularity of the heart rate 
for its success [15]. 
(b) Minimisation of respiratory artifacts 
Cardiac CT scans are performed during a single 
breath-hold to minimise motion from respiration. In 
order to achieve this, the acquisition time for the total 
coverage of the heart has to be short. The acquisition 
time for cardiac scans using the 4-slice CT scanners 
ranged between 33 and 40 sec. With the introduction of 
16-slice CT scanners, the acquisition time was reduced to 
less than 20 sec. Further reduction in acquisition time (of 
less than 10 sec) was achieved with the 64-slice CT 
scanners, further reducing the occurrence of involuntary 
motion artifacts from respiration and movements of the 
patients. 
(c) High spatial resolution 
The epicardial coronary arteries are small with 
diameters ranging from 5 mm proximally to less than 
1 mm distally. Imaging of these small structures requires 
high spatial resolution. With the introduction of the 
16-slice CT scanners, the presence of submillimetre 
detector widths has provided significant improvement in 
the in-plane (x-y) resolution. The current 64-slice CT 
scanners have detector widths ranging between 0.5 and 
0.625 mm [14]. 
(d) Adequate and uniform contrast enhancement 
Poor vessel opacification is one of the factors that 
affect the image quality of the CT examination and 
renders distal vessels to be non-evaluable. Therefore, 
contrast injection protocol must be tailored to optimise 
contrast-to-noise ratio and to obtain uniform contrast 
enhancement. This is achieved by using contrast delivery 
techniques such as the automatic bolus tracking or the 
test bolus technique. Contrast needs to be administered 
via a powered contrast medium injector. 
(e) Employment of radiation dose-reduction techniques  
Managing radiation dose to the patient during a 
cardiac CT scan is a primary concern. Various methods 
for dose-reduction are available. During the scan, the 
tube current (mA) can be modulated to be optimum at 
time of the targeted phase acquisition (usually diastolic). 
At other times, the tube current is kept at a nominal level. 
Using this technique, a dose saving of about 45% can be 
achieved, depending on the heart rate during the 
acquisition [14]. 
(f) Management of large volume of image data 
Cardiac CT using submillimetre detector thickness 
results in a large amount of image data to be 
reconstructed and interpreted. This provides a challenge 
to the clinician in management of these data. CT 
scanners currently need to be equipped with software, 
which enable these data to be visualised in the native 
axial images, multiplanar reconstruction (MPR), 
maximum intensity projection (MIP) as well as 3D 
volume rendering images. In order to do this, powerful 
workstations are needed for image reconstructions and 
evaluation. Software for measurement including 
quantitative manual and semiautomatic tools is useful for 
further analysis of coronary artery stenosis [14]. 
In view of the above requirements, it is the 
recommendation of the committee that the acceptable 
imaging systems that can be utilised for cardiac imaging 
include a minimum of a 16-slice MSCT, electron-beam 
CT or the dual-source CT scanner. At the very minimum, 
a 4-slice CT scanner is required for calcium scoring. 
INDICATIONS OF CORONARY CTA 
As coronary CTA is a relatively new imaging 
modality, there is limited clinical evidence available for 
many indications and case scenarios for which coronary 
CTA may be useful. The committee has proposed an 
‘Appropriateness Criteria’ championed by the American 
College of Cardiology Foundation [16] which blends 
scientific evidence and practical experience by engaging 
a diverse technical panel to rate each indication as 
appropriate or inappropriate application of coronary 
CTA. In formulating a consensus, these authors are 
greatly aided by the report of the American College of 
Cardiology Foundation Quality Strategic Directions 
Committee Appropriateness Criteria Working Group that 
included the American College of Radiology, Society of 
Cardiovascular Computed Tomography, Society for 
Cardiovascular Magnetic Resonance, American Society 
of Nuclear Cardiology, North American Society for 
Cardiac Imaging, Society for Cardiovascular 
Angiography and Interventions, and Society of 
Interventional Radiology [17]. 
1.  An appropriate imaging study is one in which 
the expected incremental information, 
combined with clinical judgment, exceed the 
expected negative consequences by a KH Sim et al. Biomed Imaging Interv J 2008; 4(4):e41   4 
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sufficiently wide margin for a specific 
indication that the procedure is generally 
considered acceptable care and a reasonable 
approach for that indication (negative 
consequences include the risks of radiation or 
contrast exposure and test inaccuracies). 
2.  An inappropriate test for that indication means 
that cardiac CTA is not generally acceptable 
and is not a reasonable approach for that 
indication. 
3.  In many instances, cardiac CTA may be 
regarded as generally acceptable or a 
reasonable approach for that indication but 
would require more research and/or patient 
information to classify that indication 
definitively. Examples of such indications are 
detection of CAD in patients with acute chest 
pain but without typical ECG or cardiac 
enzyme changes; patients with typical chest 
pain and previous bypass graft or coronary 
stenting procedure; and screening for CAD in 
the asymptomatic high-risk population; and 
evaluation of left ventricular function in clinical 
heart failure patients with technically limited 
images from echo. 
In deliberating the appropriateness of cardiac CTA, 
the committee evaluated only clinical evidence from 
cardiac CTA imaging using slice collimations of less 
than 1.0 mm for the detection of haemodynamically 
significant coronary artery stenosis – usually accepted as 
50% luminal stenosis or greater [8]. Any local data that 
is more relevant to the Malaysian population were also 
included [18, 19]. The indications are for coronary 
imaging and calcium scoring unless otherwise specified. 
Provided that image quality is adequate, evaluation is 
performed by cardiac CTA level 2 or 3 trained doctors 
(see under Section: Training), and the patients are 
properly chosen and prepared for the study. Cardiac CTA 
has been investigated and reported for the following 
indications: 
●  Detection of haemodynamically significant 
coronary artery disease in a heterogeneous 
group of patients.  
●  Coronary stent and bypass graft patency. 
Appropriate Indications 
1. Detection of CAD in patients with: 
●  Chest pain and intermediate pre-test probability 
of CAD [20] and: 
○  not suitable for exercise treadmill test 
(ETT); 
○  un-interpretable or equivocal functional 
tests (ETT, perfusion or stress echo); 
○  no ischaemic ECG changes and negative 
serial enzymes. 
●  Asymptomatic and low-to-moderate 
cardiovascular risk [21] but positive stress ECG;  
●  Cardiomyopathy to exclude coronary disease. 
2. Structure and Function Evaluation 
●  Suspected coronary anomalies; 
●  Assessment of complex congenital heart 
disease; 
●  Evaluation of intra-cardiac masses and 
pericardial diseases in patients with  
●  technically limited images echo, MRI or TEE; 
●  Evaluation of pulmonary vein anatomy prior to 
radiofrequency ablation for atrial  
●  fibrillation; 
●  Coronary vein mapping prior to placement of 
biventricular pacemaker. 
Inappropriate Indications 
1. Detection of CAD in patients with: 
●  Typical cardiac chest pain and high pre-test 
probability; 
●  Acute chest pain, high pre-test probability 
demonstrating ischaemic ECG changes and/or 
positive cardiac enzymes; 
●  Evidence of moderate-to-severe ischaemic on 
functional tests (ETT, perfusion, stress echo). 
2. Asymptomatic patients/population with: 
●  Low-to-moderate CV risk score for screening; 
●  High CV risk but CCTA or conventional 
angiography was normal up to 2 years 
previously. 
3. Asymptomatic patients/population without 
inducible ischaemia on functional tests for:  
●  Evaluation of bypass grafts; 
●  Evaluation of coronary stents. 
Indications for Calcium score  
Recent publications suggest calcium scoring 
provides additional prognostic information to traditional 
risk scoring methods. Calcium scoring is appropriate for 
patients deemed at medium risk for cardiovascular 
events based on risk factor models. The presence of 
calcium and the incremental levels of coronary artery 
calcium score denote higher levels of risk and hence, 
guide the aggressiveness of preventive therapies and 
target goals. This is because there are no well-defined 
boundaries of risk levels but instead a risk continuum 
relationship similar to hypertension. Calcium scoring has 
been shown to be independently predictive of 
cardiovascular risk and adds incremental prognostic 
information to the conventional risk factor scoring 
methods [22-24]. KH Sim et al. Biomed Imaging Interv J 2008; 4(4):e41   5 
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REPORTING OF CARDIAC CTA 
Format 
The documentation of a CTA report should include 
the following headings: 
1.  Patient demographics 
2.  Reporting physician(s) 
3.  Type of examination 
4.  Indication for CT angiography 
5.  CT hardware and acquisition protocols 
(scanning and contrast) 
6.  Need for beta-blocker or any adjunctive 
medications and dosage used 
7.  Adequacy of image quality 
8.  Contrast used and amount 
9.  Findings 
10.  Complication(s) if any 
11.  Conclusion(s) 
12.  Recommendations 
Reporting 
The CTA volume dataset must be examined in 
multiple reconstruction protocols including axial, 
multiplanar, and maximum intensity projection (MIP) 
[25].  
Axial images are the most valuable in evaluation of 
the coronary arteries [7, 26]. Advanced post-processing 
tools e.g. 3D-Volume-rendered techniques, MIP are most 
accurate when viewed together with the axial data. 
Proper window width and level or appropriate 
kernel should be used to visualise structure of interest or 
excessive calcification, if present. 
Every segment of the coronary tree needs to be 
examined and documented using established 
nomenclature. This paper proposes one model of the 
coronary tree segmentation (Figure 1). This would allow 
cross-referencing with findings during catheter 
angiography. It also provides standardisation in the 
reporting which is crucial for clinical trials and 
communication. Presence of non-assessable segments 
should be noted. 
In reporting the coronary arteries, dominance, 
presence of variants and anomalies should be noted. 
Description of plaques should include segmental location, 
extent of disease, attenuation characteristics, degree of 
stenosis and presence of vessel remodelling. 
Stenosis quantification is based on referencing to 
adjacent segment’s luminal calibre rather than vessel 
luminal wall to outer wall diameter. Vessel cross-
sectional and longitudinal views should be used for 
estimation [25]. Stenosis quantification can be performed 
by visual estimate and/or electronic callipers. Lesion 
severity are usually categorised as mild, moderate, severe 
or occluded which corresponds to stenotic severities of 
<50%, 50-70%, >70% and 100% narrowing. Plaque 
attenuation characteristics may be described e.g. 
calcified, non-calcified or mixed. Special features e.g. 
plaque ulceration, vessel dissection, and thrombus may 
sometimes be seen.  
Additional information may be reported by experts 
if optimal images are available e.g. cardiac chambers 
(size, morphology), myocardium (thinning, contour 
change or attenuation difference), pericardium (masses, 
thickness, calcification, effusion) and extra-cardiac 
structures.  
Information on cardiac function and valve structures, 
and function may be obtained with other post-processing 
methods if needed. 
 
mid RCA (2) 
Prox RCA 1(1) 
Distal RCA (3) 
Left main (5)
Prox LAD(6) 
Diagonal 1 (9) 
mid LAD (7)
Diagonal 2 (10) 
Distal LAD (8)
R.intermedius(17) Prox LCX (11)
Ob. marginal 1(12)  
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Figure 1  Modified 17-segment of the AHA reporting system [28]. KH Sim et al. Biomed Imaging Interv J 2008; 4(4):e41   6 
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Bypass graft assessment  
Volume-rendering technique (VRT) displays good 
3D-orientation of the grafts and the target anastomostic 
sites [2, 27]. Venous grafts are well visualised by CTA 
owing to its larger size and lack of mobility. Graft 
disease and stenosis are reported in a manner similar to 
native coronary arteries. Presence of surgical clips and 
often dense calcification in native vessels of post-CABG 
patients may give rise to artifacts that make assessment 
rather challenging. 
Stent assessment  
Limited reports are currently available on stent 
evaluation with MSCT [27]. The accuracy of assessment 
is influenced by the type and size of stents. Owing to the 
high attenuation from stent material, appropriate window 
width and level or kernels should be chosen. Intrastent 
filling defects owing to in-stent restenosis (ISR) / 
occlusion should be noted. Adequacy of stent expansion 
may explain the reason for restenosis.  
RADIATION PROTECTION IN CARDIAC CT  
The major drawback of imaging of the heart using 
multislice MSCT is the high radiation dose. The effective 
dose for coronary angiography using EBCT ranges from 
1.5 to 2.0 mSv while a similar examination using 4-slice 
MSCT ranges from 6 to 13 mSv [29]. Recent MSCT 
multicentre studies have documented higher radiation 
doses of up to 30 mSv in day-to-day practice. However, 
with dose reduction techniques such as ECG-dependent 
dose modulation as mentioned before, dose saving of 
about 45% can be achieved. In a study by Hausleiter et 
al., the use of ECG-dependent dose modulator resulted in 
a significant reduction in the effective dose estimate 
from 10.6 ± 1.2 to 6.4 ± 0.9 (using 16-slice MSCT 
scanner) and 14.8 ± 1.8 to 9.4 ± 1.0 mSv (using 64-slice 
MSCT scanner) [30]. The new ‘step and shoot’ technique 
available in some systems today allows a 50-80% dose 
reduction [31]. 
It is imperative then that the principles of radiation 
exposure namely justification, limitation and ALARA 
(As Low As Reasonably Achievable) should be upheld at 
all times. Therefore, in view of the considerable radiation 
doses, it is the recommendation of the committee that: 
1.  The decision to expose a patient to cardiac CT 
has to be made by physicians aware of the 
radiation risks that will be incurred by the 
patient. At the time of writing, CT coronary 
artery angiography is not considered as a 
screening procedure and each patient should 
have justifiable indications to undergo the 
procedure. The use of MSCT for calcium 
scoring for risk stratification purposes are 
acceptable in clinical practice. 
2.  The use of dose-reduction techniques should be 
employed whenever possible. Effective dose 
during cardiac CT should ideally not exceed 
13  mSv [29]. Special care should be taken 
when imaging children and young female (as 
the breast would be included in the scanning 
field). 
SAFETY ISSUES IN CARDIAC CT  
Safety issues in cardiac CT involve issues regarding 
radiation, intravenous contrast administration and 
administration of β-blockers and nitrates. 
Issues regarding radiation have been mentioned 
before. It is important that all personnel involved in 
cardiac CT are aware of radiation risks and undergo 
basic training in radiation effects and radiation protection.  
Risks with contrast media administration include 
adverse reactions to the contrast, its nephrotoxic 
properties and risk of extravasation. The supervising 
physician should be able to identify patients with 
increased risk of developing adverse reactions or in 
which contrast media is contraindicated. Patients with 
renal failure should also be identified. The physician 
should be well versed in treating and managing contrast 
media reactions. 
β-blockers are currently the preferred method to 
reduce heart rate. Supervising physicians should be 
aware of the dosage, action and the contraindications of 
β-blockers. 
TRAINING IN CARDIAC CT  
CT is an important imaging modality for the 
detection and characterisation of cardiac disease; 
therefore it is crucial that physicians who supervise and 
interpret cardiac CT should have appropriate competency, 
experience and expertise [32]. 
Competencies are divided into:  
1.  Criteria for performing calcium scoring 
exclusively only. 
2.  Criteria for interpreting cardiac CT  
a.  level 1 competency 
b.  level 2 competency 
c.  level 3 competency 
1. Criteria for performing calcium scoring exclusively 
only 
Any physicians such as cardiologists and 
radiologists who are certified from the acceptable 
body/board and have undergone training which includes 
cardiac anatomy and experience with training in 
interpretation of cross-sectional imaging are qualified to 
interpret coronary artery calcium scoring [32].  
2. Criteria for interpreting cardiac CT  
Physicians should have adequate knowledge and 
understanding of the anatomy, physiology and 
pathophysiology of the cardiac systems for cardiac CT 
interpretation.  KH Sim et al. Biomed Imaging Interv J 2008; 4(4):e41   7 
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a) Level 1 competency  
This is defined as the minimal introductory training 
for familiarity with CCTA but is not sufficient for 
independent interpretation of the CCTA studies [33, 34]. 
The trainee should have been actively involved in CCTA 
interpretation under the direction and supervision of a 
qualified level 2 or 3 mentor.  
The trainee should undergo mentored interpretation 
of at least 25 cases of CCTA with contrast (of which a 
minimum of 10 cases should be in correlation with 
conventional coronary angiography). Studies may be 
taken from an established teaching file or previous CCT 
cases. Trainees are required to provide proof of training 
(e.g. verified log book, letter of certification by a 
qualified level 2 or 3 mentor). 
b) Level 2 competency  
This is defined as the minimum level of training for 
a doctor to independently perform and interpret CCTA 
[33, 34]. This is intended for individuals who wish to 
practise or be actively involved with CCTA. The doctors 
at this level should have sufficient training to interpret 
the CT examination accurately and independently. 
The trainee should undergo mentored interpretation 
of at least 75 cases of CCTA, of which the trainee must 
perform at least 15 cases under supervision of a qualified 
level 2 or 3 mentor. A minimum of 25 should be 
correlated with coronary angiography. Studies may be 
taken from an established teaching file or previous 
CCTA cases.  
The trainee should also undergo training in 
advanced anatomy, contrast administration, principles of 
3-dimensional imaging/post-processing, principles of 
radiation protection and its hazards to patients and 
personnel, and appropriate post-procedural patient 
monitoring. 
Trainees are required to provide proof of training 
(e.g. verified log book, certificate of attendance, letter of 
certification by a qualified level 2 or 3 mentor) 
c) Level 3 competency 
This represents the highest level of expertise that 
would enable an individual to serve as a director of a 
cardiac CT centre [33, 34]. This person would also be 
directly responsible for quality control and training of 
radiographers. 
This requires a further minimum cumulative training 
period of 6 months after completion of level 2 training. 
Trainee should interpret at least 150 cases of CCTA. The 
cases reflect the broad range of pathology expected in 
cardiac imaging. The trainee must be involved in 
performing at least 75 cases and ongoing participation in 
quality assurance and safety programmes as well as be 
involved in research activities. Studies may be taken 
from an established teaching file or previous CCTA 
cases.  
Trainees are required to provide proof of training 
(e.g. verified log book, certificate of attendance, and 
letter of certification by a qualified level 3 mentor) 
TRAINING REQUIREMENTS FOR RADIOGRAPHERS 
CT radiographers should possess a diploma in 
radiography, or any equivalent radiography 
qualifications recognised by the Ministry of Health 
Malaysia or Society of Radiographers Malaysia. 
It is encouraged that the radiographers performing 
the cardiac CT have advanced certification in at least 
post-basic CT. The radiographers must also be able to 
prepare, position, ensure patient safety, monitor the 
patient, apply the contrast injection and scanning 
protocol as prescribed by supervising doctors. They 
should also perform regular quality control testing [32]. 
If the radiographer does not have an advanced 
certification in CT, a minimum of 3 months full-time CT 
training is required under the supervision of a suitably 
trained CT radiographer and radiologist before being 
allowed to operate a CT scanner independently. 
Radiographers are encouraged to keep a log book of the 
number of CT cases performed.  
The radiographer should also have adequate 
Continuous Professional Development (CPD) on CCTA-
related topics (at least attend one conference / workshop / 
course every 2 years). 
CT scanners should not be operated by any person 
without the above stated qualifications e.g. medical 
physicists, technicians, research staff, post-doctorate 
fellows, nurses and any other non-radiological qualified 
staff. 
Intravenous contrast materials can be administered 
by radiographers and nurses under the direction of 
supervising doctors, if the practice is in compliance with 
institutional regulations.  
EXTRACARDIAC FINDINGS OF CORONARY CTA 
CT scans performed for cardiac evaluation includes 
visualisation of extracardiac structures within its scan 
range. The importance of this is two-fold. Firstly, some 
of the risk factors for CAD such as smoking, male sex, 
and age overlap with the risk factors for other chest 
diseases such as bronchial carcinoma [35]. 
Secondly, chest pain is not unique to cardiac disease, 
and may be a result of other chest pathology [36, 37].  
With the same raw data, at no additional radiation 
exposure to the patient, reconstructions of the images 
into a larger field of view allow visualisation of the lung 
and chest wall at the level of scan. Dedicated coronary 
artery CT focused on the heart displays 35.5% of total 
chest volume, while images reconstructed at maximal 
field of view visualises 70.3% [35]. 
Studies have shown that cardiac CT demonstrated a 
significant number of previously unknown extracardiac 
findings, some of which had an immediate impact on 
workup, follow-up or both. The incidence of extracardiac 
findings ranged from 7.8 to 58.1% [37, 38]. The 
extracardiac findings that required some form of therapy 
was 3 to 5% [35, 37]. These included pulmonary 
embolism, bronchogenic carcinoma, liver tumours and KH Sim et al. Biomed Imaging Interv J 2008; 4(4):e41   8 
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congenital anomalies. Evaluation of extracardiac 
structures should be performed by a radiologist. 
However, cardiac scans have a small field of view 
restricted to the heart which precludes a complete 
evaluation of the thorax. Therefore both patients and 
referring physicians have to understand that the focus of 
the cardiac CT is for the detection of cardiac diseases.  
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APPENDIX 
Pre-Test Probability and 10-year Absolute Risk of 
Coronary Artery Disease (CAD) 
Pre-Test Probability 
The Pre-test Probability estimates the likelihood of 
coronary artery disease (defined as presence of angina 
pectoris, recognised and unrecognised myocardial 
infarction, unstable angina, and CHD deaths) for any 
given patient based upon the type of presenting 
symptoms, age and gender. The risk generally increases 
with age. 
●  High: Greater than 90% pre-test probability;  
●  Intermediate: Between 10% and 90% pre-test 
probability;  
●  Low: Between 5% and 10% pre-test 
probability;  
●  Very Low: Less than 5% pre-test probability.  
Coronary Artery Disease (CAD) Risk  
The risk of developing coronary artery disease 
during a 10-year period may be calculated from a 
multifactorial equation recommended by, and 
summarised in the AHA/ACCF Joint report, ACC/AHA 
Scientific Statement: Assessment of Cardiovascular Risk 
by Use of Multiple-Risk-Factor Assessment Equations 
[21]. The equation takes into account gender, age, total 
cholesterol, HDL cholesterol, smoking history, presence 
of left ventricular hypertrophy and diabetes. For example, 
Low-risk level is defined in the Framingham Report as 
the risk of coronary heart disease (CHD) at any age for a 
non-smoker, non-diabetic, with blood pressure less than 
120/80 mmHg, total cholesterol of 4.0-5.0 mmol/L, 
LDL-C 2.5-3.2 mmol/L, and HDL-C greater than or 
equal to 1.13 mmol/L in men and greater than or equal to 
1.39 mmol/L in women.  
●  Low Risk: 10-year absolute risk of less than 
10%; generally risk is below age-specific risk 
level. 
●  Medium risk: 10-year absolute risk 10 to 20%; 
risk is average or above average of age specific 
risk level. 
●  High Risk: Presence of Diabetes Mellitus or 
10-year absolute risk greater than 20%.  
Notes to Statement 
Use of words “physician”, “doctor”, “radiologist” 
and “cardiologist” in this document: 
Physician refers to any medically-trained doctor 
from recognised institutions and registered with the 
Malaysian Medical Council. A doctor is synonymous 
with a physician in this document. A radiologist or 
cardiologist, if specified would refer to a medical 
doctor/physician who has received the recognised 
training in the specialty of radiology and cardiology 
respectively.  
Table 1  Pre-test Probability of Coronary Artery Disease by Age, Gender and Symptoms (Reproduced from 
ACC/AHA 2002 Guideline Update for Exercise Testing) [20]. 
Age (yrs)  Gender  Typical/Definite 
Angina Pectoris 
Atypical/Probable 
Angina Pectoris 
Nonanginal 
Chest Pain 
Asymptomatic 
30 – 39  Men  Intermediate  Intermediate  Low  Very low 
  Women  Intermediate  Very low  Very low  Very low 
40 – 49  Men  High  Intermediate  Intermediate  Low 
  Women  Intermediate  Low  Very low  Very low 
50 – 59  Men  High  Intermediate  Intermediate  Low 
 Women  Intermediate  Intermediate  Low  Very  low 
60 – 69  Men  High  Intermediate  Intermediate  Low 
 Women  High  Intermediate  Intermediate  Low 